Setting the Record Straight on Gardasil

US Court Orders Merck To Turn Over Gardasil Adverse Event Databases

A North Carolina district court has ordered Merck to turn over all of its Gardasil adverse events databases to plaintiffs suing the big pharma giant for injuries they claim were caused by the human papillomavirus (HPV) vaccine. Gardasil is a widely used vaccine commonly administered to both male and female teens and young adults before they are sexually active to protect against HPV infections. Most infections are benign and resolve on their own. Dozens of lawsuits have been filed by individuals claiming they have suffered a range of injuries after taking Gardasil, including autoimmune disorders, premature ovarian failure, chronic fatigue, pain and even cancer.

A North Carolina district court has ordered Merck to turn over all of its Gardasil adverse events databases to plaintiffs suing the big pharma giant for injuries they claim were caused by the human papillomavirus (HPV) vaccine.

The databases, which include information from the Merck Adverse Event Reporting and Review System (MARRS), should contain all of the reports pertaining to Gardasil adverse events submitted by physicians, patients and publications, plaintiffs’ attorney Michael Baum told the Defender.

Dozens of lawsuits have been filed by individuals claiming they have suffered a range of injuries after taking Gardasil, including autoimmune disorders, premature ovarian failure, chronic fatigue, pain and even cancer.

The Defender reports: In his March 20 order, U.S. District Judge Robert J. Conrad, Jr., said, “Plaintiffs’ and their experts should have the same opportunity as Merck to review and analyze the entirety of the data.”

Merck until now has refused to make the entire MARRS databases available to the plaintiffs’ attorneys.

Gardasil is a widely used vaccine commonly administered to teens and young adults before they are sexually active to protect against HPV infections, which can be sexually transmitted later in life.

HPV infections may lead to the development of cervical cancer. However, most infections are benign and resolve on their own.

The firm Baum Hedlund Aristei & Goldman and Robert F. Kennedy, Jr., Children’s Health Defense chairman-on-leave, have filed more than two dozen lawsuits on behalf of young people injured by Gardasil, alleging Merck knowingly and fraudulently concealed the vaccine’s risks.

Read full article here…

from:    https://needtoknow.news/2023/04/us-court-orders-merck-to-turn-over-gardasil-adverse-event-databases/

Gardasil Results in Japan

Japan Leading the World in Exposing Fraud with Gardasil HPV Vaccine Injuries and Deaths

In Japan, young women and girls suffering from severe chronic generalized pain following vaccination with Merck’s Gardasil® or GSK’s Cervarix®, have organized and are speaking out.

The issues are being debated at public hearings, at which scientific presentations have been made by independent medical experts who validated the women’s suffering with documented evidence of the severe nature of the pain related to the HPV vaccine.

The opposing view, presented by scientists aligned with the vaccine establishment, disregarded the scientific plausibility of the evidence and declared the pain was a “psychosomatic reaction.”[1]

Such public debates do not take place where vaccine stakeholders are in full control of vaccine safety information. (Like in the U.S., for example.)

Public Hearings Regarding Hpv Vaccine Injuries In Japan Are Allowed Because Pro Vaccine Forces Are Not In Full Control Of Public Health Policies.

Following a public hearing (February 2014), at which scientific evidence was presented by independent scientists [2], the Japanese government, not only rescinded its recommendation that girls receive the HPV vaccine, but established guidelines and special clinics for evaluating and treating illnesses caused by the vaccine.

It is a scenario that Merck, GSK, and vaccine stakeholders globally are extremely anxious to suppress.

The Merck-commissioned, CSIS report, co-authored by Dr. Larson, paints a picture of an all-out war over media coverage – not over the high rate of serious adverse reactions.

The authors resort to the usual tactic of discrediting vaccine-injured individuals; they dismissed the serious health effects suffered by girls and young women following vaccination, as trivial.

The CSIS report presents the entire issue as an epidemic fueled by Internet rumors and “vaccine hesitators.”

“Over the last year, controversy within the Japanese medical and political arenas over the HPV vaccine has touched the public at large. Through social media and highly publicized events, anti-vaccine groups have gained control of the narrative surrounding the HPV vaccine.”

Global Collaborators in Action: Trash Honest Scientists to Suppress Inconvenient Evidence

Hpv Doctors

The following case demonstrates how the global network of government/academic and industry stakeholders suppresses information about genuine scientific findings and, when needed, is engaged in corrupt practices to thwart the airing of information about vaccine safety issues.

This case involves inconvenient scientific laboratory findings in post-mortem tissue samples, showing that the HPV vaccine was contaminated with foreign HPV DNA fragments. The case also involves evidence (contained in internal correspondence) of deceptive practices by officials of “authoritative” international public health institutions.

In January 2016, pathologist Dr. Sin Hang Lee, MD, Director of Milford Medical Laboratory, sent an open letter of complaint to the Director-General of the World Health Organization (WHO), Dr. Margaret Chan, in which he challenges the integrity of the GACVS Statement on the Continued Safety of HPV Vaccination (issued March 2014), and charges professional misconduct on the part of the following individuals (and suggests that others may have also been actively involved) in a scheme to deliberately mislead the Japanese Expert Inquiry on human papillomavirus (HPV) vaccine safety before, during and after the February 2014 public hearing in Tokyo.

Dr. Lee challenged the integrity of the GACVS Statement on the Continued Safety of HPV Vaccination written by Dr. Pless, accusing him of deliberately misrepresenting his scientific findings in order to mislead non-scientific readers and those who set vaccination policies.

Dr. Pless is accused of deliberately conflating two unrelated articles, dealing with two different chemicals, written by different authors “apparently to create a target to attack.” Furthermore, Dr. Lee notes that the GACVS Statement relied on an unpublished 12-year-old “Technical Report” written by an unofficial, unnamed “group of participants” (according to CDC’s disclaimer).

These are the facts:

In 2011, Dr. Lee found that every one of the 13 Gardasil samples that he examined contained HPV L1 gene DNA fragments.

He also found that the HPV DNA fragments were not only bound to Merck’s proprietary aluminum adjuvant but also adopted a non-B conformation, thereby creating a new chemical compound of unknown toxicity.

This non-B conformation, Dr. Lee believes, is responsible for the array of autoimmune illnesses experienced by children and young women following vaccination with Gardasil.

In 2012, Dr. Lee testified at a coroner’s inquest of the death of a New Zealand teenager, 6 months after receiving 3 Gardasil vaccine injections.

He then published his case report in the open access journal, Advances in Bioscience and Biotechnology (2012).

Dr. Lee was a presenter at the Tokyo hearing (2014), at which he disputed those who claimed the young women weren’t really suffering severe pain; they were having “psychosomatic reactions.” He stated:

“I do not believe psychosomatic reactions can cause sudden unexpected death in sleep, or inflammatory lesions in the brain as demonstrated by the MRI images and the brain biopsy histopathology with perivascular lymphocytes and macrophages and demyelination.”

Following the public hearing, GAVC issued a statement (March 12, 2014) aimed at discrediting Dr. Lee’s research by conflating his research with the research of other scientists who presented at the Tokyo hearing.

This case should have been prominently reported in the medical journals and by the mass media, and the allegation should have been investigated.

Mainstream publications have been silent; the case was reported only in alternative news outlets. [3]

In July 2016, a victims’ group filed a multi-plaintiff lawsuit in the district courts of Tokyo, Nagoya, Osaka, and Fukuoka against the Japanese government and the two pharmaceutical companies that had produced these vaccines.

Furthermore, in December of the same year, additional victims joined the multi-plaintiff lawsuit, bringing the total number of plaintiffs to 119 (Indian Journal of Medical Ethics, 2017).

The Hazards of Aluminum in Vaccines Is the Focus Of Intense Research

Of note: the placebo comparator in (most) vaccine clinical trials is not inert, it contains aluminum.

Several independent teams of international autoimmune experts have investigated this, led by the internationally recognized authority of autoimmune diseases, Dr. Yehuda Shoenfeld of Tel Aviv University, Israel, and another group by Dr. Christopher Exley, Professor of Bioinorganic Chemistry, Keele University in the UK.

However, studies that document the hazards of aluminum in vaccines are not published in major influential medical journals.

Recent surveys of those journals document that medical journal editors have concealed financial conflicts of interest. Most Editors of Top Medical Journals Receive Industry Payments (Retraction Watch, Nov. 2017).

In two cases, journal editors received over $1 million from industry sources. (Ed Silverman, STAT, 2017.)

The following case is an example of how science is subverted by tightly controlled journal gatekeepers. Journal editors who have sold their integrity by accepting industry kickbacks block publication of reports that might pose a financial threat to an intricate web of government and non-government institutions and professional associations – all of whom are financially tied to the pharmaceutical industry.

The case demonstrates the great difficulty encountered by independent scientists who have not sold their integrity to the highest bidder.

Publication Saga: Case Examples of Harassment Aimed At Suppressing Harmful Findings Regarding the HPV-Gardasil Vaccine

The study, Behavioral Abnormalities In Young Female Mice Following Administration Of Aluminum Adjuvants And The Human Papillomavirus (HPV) Vaccine Gardasil, was conducted in Israel by a team of researchers headed by Professor Yehuda Schoenfeld, an internationally recognized authority, who is considered to be the pillar in the field of autoimmunity.

Indeed, Dr. Shoenfeld identified a new syndrome ASIA (Autoimmune/Inflammatory Syndrome Induced by Adjuvants).

“The idea of ASIA as a new syndrome developed after some studies on Gulf War syndrome reported that soldiers who had not been deployed to the Gulf area were suffering from symptoms such as severe fatigue, cognitive impairment, myalgias and arthralgias. This raised the question of whether it was the vaccines administered to the soldiers that induced these syndromes. The most common adjuvants are silicone implants and aluminum in vaccines.” [4]

The focus of the research seeks to shed light on “the roles and mechanisms of action of different adjuvants which lead to autoimmune/ inflammatory response.”

Prof. Shoenfeld encountered blockades from journal editors who attempted to suppress the findings of neuroinflammation and “behavioral abnormalities following administration of aluminum adjuvants and the HPV vaccine Gardasil.”

Those editors have financial stakes in the business of vaccines.

Dr. Michael Racke
             Dr. Michael Racke

The HPV-mouse study was first submitted to for publication to the Journal of Human Immunology where it was shelved for 8 months and was then rejected by that journal’s Editor-in-Chief, Dr. Michael Racke.

According to the American Academy of Neurology:

“Dr. Racke has received personal compensation for activities with EMD Serone, Novartis, Roche Diagnostics Corporation, Genentech, and Amarantus as a consultant.”

EMD Serono, Inc. is a subsidiary of Merck KGaA, Darmstadt, Germany.

The HPV-mouse study was published in the journal Vaccine in January 2016.

It was summarily withdrawn a month later following orders by the Editor-in-Chief, Gregory Poland. [5]

Dr. Poland’s direct conflicts of interest [5] include those disclosed on the Mayo Clinic website:

“Dr. Poland is the chairman of a safety evaluation committee for investigational vaccine trials being conducted by Merck Research Laboratories. Dr. Poland offers consultative advice on new vaccine development to Merck & Co., Inc. [Dr. Robert Chen is an Associate Editor of Vaccine.]”

How is it that this incestuous relationship did not raise loud cries of foul play? Those rejections by editors who had deeply vested financial interest in protecting vaccination rates, whose own financial interest was intertwined with vaccine manufacturers, elicited no protest from the scientific academic community.

Instead, these rejections were followed by vicious attacks against two of the scientists by industry’s cyber hit-squads that are hired to attack independent scientists whose honest research contradicts vaccine orthodoxy. That is viewed as a heresy inasmuch as it poses a financial threat. [6]

The study was revised, again peer-reviewed, and published in the journal Immunological Research (Nature-Springer) (2017). [7]

The reported findings remained the same:

“Vaccine adjuvants and vaccines may induce autoimmune and inflammatory manifestations in susceptible individuals. To date most human vaccine trials utilize aluminum (Al) adjuvants as placebos despite much evidence showing that Al in vaccine-relevant exposures can be toxic to humans and animals…It appears that Gardasil via its Al adjuvant and HPV antigens has the ability to trigger neuroinflammation and autoimmune reactions, further leading to behavioral changes…”

“In light of these findings, this study highlights the necessity of proceeding with caution with respect to further mass-immunization practices with a vaccine of yet unproven long-term clinical benefit in cervical cancer prevention.”

The basis for those findings was deemed to be scientifically sound by three sets of peer-reviewers, at three different journals.

By Vera Sharav, Alliance for Human Research Protection – via Healthimpactnews.com

Note: This article was extra from Vera Sharav‘s article Betrayal of Public Trust & Institutional Corruption: Vaccine Safety Ratings & Vaccine Science Falsified – which is part of a multi-document series about vaccine fraud and Dr. Andrew Wakefield’s persecution for exposing the truth regarding vaccines.

from:   https://humansarefree.com/2019/11/japan-exposing-vaccines-fraud.html  (Find References list there.)

Merck & MMR Vaccine

Merck Accused of Lying about Vaccine Effectiveness

July 10 2012

Story at-a-glance

  • Two virologists have filed a federal lawsuit against Merck, their former employer, alleging the vaccine maker overstated the effectiveness of their mumps vaccine, which may have cost the US government hundreds of millions of dollars over the past decade. They claim they “witnessed firsthand the improper testing and data falsification in which Merck engaged to artificially inflate the vaccine’s efficacy findings”
  • Chatom Primary Care has also filed a federal antitrust class action lawsuit against Merck, alleging Merck went to great lengths to manipulate test procedures and falsifying results to prop up fraudulent efficacy claims, thereby maintaining its monopoly on the MMR vaccine
  • These two lawsuits couldn’t come at a more precarious time for Merck, as the Italian Health Ministry recently conceded the MMR vaccine caused autism in a now nine-year old boy—albeit this news has been effectively censored in the US
  • A recent review of the varicella (chickenpox) vaccination program in the U.S. concluded that the vaccine has not proven to be cost-effective; increased the incidence of shingles; failed to provide long-term protection from the disease it targets―chicken pox―and; is less effective than the natural immunity that existed in the general population before the vaccine. Vaccine efficacy was found to have declined well below 80 percent by of 2002

By Dr. Mercola

Things aren’t going so well lately in the litigation department for Merck, which stands accused of lying according to not just one, but two class-action lawsuits.

In the first case, two former Merck virologists accuse their former employer of overstating the effectiveness of the mumps vaccine in Merck’s combination MMR shot, which may have cost the US government hundreds of millions of dollars over the past decadei.

Merck’s mumps vaccine was originally licensed 45 years ago. Since the 1970s, it’s been part of the trivalent measles, mumps and rubella (MMR) vaccine, which is part of the recommended childhood vaccination schedule. The case, which was initially filed in 2010, was unsealed late last month. As reported by the Courthouse News Serviceii:

“… Stephen Krahling and Joan Wlochowski were Merck virologists who claim in their unsealed complaint that they “witnessed firsthand the improper testing and data falsification in which Merck engaged to artificially inflate the vaccine’s efficacy findings.”

… As the largest single purchaser of childhood vaccines (accounting for more than 50 percent of all vaccine purchases), the United States is by far the largest financial victim of Merck’s fraud,” according to the 2010 False Claims Act complaint.”

According to Nasdaq.comiii:

“Merck–which stressed that none of these allegations relate to the safety of its product–said the lawsuit is “completely without merit”, and that it plans to “vigorously defend itself.”

It’s quite interesting to note the chosen language in Merck’s rebuttal. It in no way addresses the issue of the vaccine’s effectiveness, which is the core issue of the lawsuit and the allegation by the two former Merck employees that the drug company purposefully used improper testing methods and falsified data to make the mumps vaccine appear highly effective when the opposite was true. Instead, Merck responds by saying that none of the lawsuit’s allegations relate to the safety of its products. Such evasive maneuvering certainly gives the appearance of an admission of guilt.

Second Lawsuit Filed

A mere week after the first case was unsealed, a federal antitrust class action lawsuit was filed by Chatom Primary Care. According to Courthouse News Serviceiv:

“Merck has known for a decade that its mumps vaccine is “far less effective” than it tells the government, and it falsified test results and sold millions of doses of “questionable efficacy,” flooding and monopolizing the market, a primary caregiver claims in a federal antitrust class action.

… Chatom says in its antitrust complaint that Merck falsely claims its mumps vaccine is 95 percent effective. That claim “deterred and excluded competing manufacturers,” who would enter the risky and expensive vaccine market only if they believed they could craft a better product…

Merck is the only manufacturer licensed by the FDA to sell the mumps vaccine in United States, and if it could not show that the vaccine was 95 percent effective, it risked losing its lucrative monopoly… That’s why Merck found it critically important to keep claiming such a high efficacy rate, the complaint states. And, Chatom claims, that’s why Merck went to great lengths, including “manipulating its test procedures and falsifying the test results,” to prop up the bogus figure, though it knew that the attenuated virus from which it created the vaccine had been altered over the years during the manufacturing process, and that the quality of the vaccine had degraded as a result.”

According to these two lawsuits, Merck began a sham testing program in the late 1990’s to hide the declining efficacy of the vaccine. The objective of the fraudulent trials was to “report efficacy of 95 percent or higher regardless of the vaccine’s true efficacy.” This program was initially referred to as “Protocol 007,” the Chatom claim states, and instead of testing the vaccine’s efficacy against a wild mumps virus, as is the norm, Merck used its own attenuated strain of the virus—the identical strain with which the children were being vaccinated!

That’s as brilliant as it is devious, and a perfect example of how medical research can be manipulated to achieve desired results. Suzanne Humphries recently wrote an excellent summary for GreenMedInfo.com, explaining in layman’s terms how the tests were manipulated (see Sources). The two virologists bringing the lawsuit against Merck claim they witnessed firsthand this deception and were asked to directly participate in it.

As reported by the Courthouse News Servicev:

“That “subverted” the purpose of the testing regime, “which was to measure the vaccine’s ability to provide protection against a disease-causing mumps virus that a child would actually face in real life. The end result of this deviation … was that Merck’s test overstated the vaccine’s effectiveness,” Chatom claims.

Merck also added animal antibodies to blood samples to achieve more favorable test results, though it knew that the human immune system would never produce such antibodies, and that the antibodies created a laboratory testing scenario that “did not in any way correspond to, correlate with, or represent real life … virus neutralization in vaccinated people,” according to the complaint.

Chatom claims that the falsification of test results occurred “with the knowledge, authority and approval of Merck’s senior management.”

Health versus Profits

Considering the extent of the allegations here, it is really shocking that the conventional media has not picked up on this story. About the only major media source reporting on it was Forbes Magazinevi

to read more and see the video, go to:    http://articles.mercola.com/sites/articles/archive/2012/07/10/merck-lying-about-vaccine-effectiveness.aspx?e_cid=20120710_DNL_artNew_1